Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Vaccines | Infections and Infectious Diseases | Family Medicine
Bacterial Infections Clinical Trials
A listing of Bacterial Infections medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Illinois
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago Illinois 60611Updated
Patients are needed to participate in a clinical research study evaluating Dalbavancin for the treatment of Bacterial Infections
Indiana
Community Clinical Research Center
Anderson Indiana 46011
Efficacy, Immunogenicity, and Safety Study of Clostridium difficile Vaccine in Subjects at Risk of C. difficile Infection
Kansas
GSK Investigational Site
Overland Park Kansas 66211
Patients are needed to participate in a clinical research study to evaluate Bacterial Infections
North Carolina
Duke Medical Center
Durham North Carolina 27710Updated
Patients are needed to participate in a clinical research study evaluating Dalbavancin for the treatment of Bacterial Infections
Oklahoma
The Children's Hospital at the University of Oklahoma Medical Center
Oklahoma City Oklahoma 73013
A clinical research study of Daptomycin for the treatment of Chronic Kidney Disease or Bacterial Infection
Australia
CMAX
Adelaide South Australia 5000
A clinical research study of RPX7009, RPX2014, Placebo and Combination RPX7009 and RPX2014 for the treatment of Healthy Volunteers or Bacterial Infections
Finland
Sanofi Pasteur MSD Investigational Site 003
Espoo
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 001
Helsinki
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 002
Helsinki
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 011
Jarvenpaa
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 010
Kokkola
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
View More »
Sanofi Pasteur MSD Investigational Site 004
Oulu
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 005
Pori
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 009
Seinajoki
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 006
Tampere
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 007
Turku
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 008
Vantaa
Patients are needed to participate in a clinical research study evaluating Hexavalent vaccine, NeisVac-C, Prevenar 13 and RotaTeq for the treatment of Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Philippines
De La Salle Health Sciences Institute
Dasmariñas City Cavite 4114
Patients are needed to participate in a clinical research study evaluating 100 mg Delamanid and 50 mg Delamanid for the treatment of Multidrug Resistant Tuberculosis or Pediatric
De La Salle Health Sciences Institute
Dasmariñas City Cavite
Patients are needed to participate in a clinical research study of Delamanid to evaluate Multidrug Resistant Tuberculosis or Pediatric
Lung Center of the Philippines
Quezon City Metro Manila
Patients are needed to participate in a clinical research study of Delamanid to evaluate Multidrug Resistant Tuberculosis or Pediatric
Singapore
Singapore General Hospital
Singapore
A Phase 1/Phase 2 clinical study for patients with Helicobacter Pylori Infection
National University Hospital
Singapore
A Phase 1/Phase 2 clinical study for patients with Infectious Disease or Bacterial Infections
South Africa
Brooklyn Chest Hospital
Ysterplaat Cape Town
Patients are needed to participate in a clinical research study evaluating 100 mg Delamanid and 50 mg Delamanid for the treatment of Multidrug Resistant Tuberculosis or Pediatric
Brooklyn Chest Hospital
Ysterplaat Cape Town
Patients are needed to participate in a clinical research study of Delamanid to evaluate Multidrug Resistant Tuberculosis or Pediatric
Spain
Sanofi Pasteur MSD Investigational Site 004
A Coruña
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 015
Almeria
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 012
Burriana
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 010
Cuart de Poblet
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 008
La Eliana
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
View More »
Sanofi Pasteur MSD Investigational Site 011
Paiporta
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 001
Santiago de Compostela
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 014
Sevilla
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 007
Valencia
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 013
Valencia
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 009
Valencia
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
Sanofi Pasteur MSD Investigational Site 005
Vilagarcia de Arousa
Patients are needed to participate in a clinical research study to evaluate Neisseria Meningitidis, Bacterial Infections or Virus Diseases
United Kingdom
Research Site
London
Patients are needed to participate in a clinical research study evaluating Avibactam (AVI), Aztreonam (ATM), combination of Aztreonam - Avibactam (ATM-AVI) and Placebo for the treatment of Complicated Infection or Bacterial Infections